Page 393 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 393
Dr. Falk Pharma GmbH 330 J
5, Leinenweberstrasse
Freiburg, 79108
Germany
www.drfalkpharma.de
Dr. Falk Pharma GmbH is an independent family owned enterprise based in Freiburg/
Germany with affiliates in UK,The Benelux countries, Spain, Portugal and Russia. Dr. Falk
Pharma and its approximately 200 employees are specialised in the development and sales
of medication for indications in hepatology and gastroenterology.These, mainly prescription
drugs, are sold in more than 60 countries worldwide.
The Falk Foundation e.V. is an independent organisation associated with Dr. Falk Pharma,
offering a wide variety of congresses and media to support postgraduate education for
doctors on a national and international level.
Echosens 320 A
30 place d'Italie
Paris, 75013
France
www.echosens.com
Echosens is a pioneer in non-invasive diagnosis solutions in hepatology. FibroScan®, based on
proprietaryVCTE: the only worldwide clinically validated medical device using elastography
(+900 publications). FibroMeter: a range of scores combining blood biomarkers to measure
fibrosis in the liver. FibroView: a range of smart connectivity solutions.
Epistem Ltd 250 D
48 Grafton Street
INDUSTRY INFORMATION
Manchester, M13 9XX
United Kingdom
www.epistem.co.uk or www.genedrive.com
Epistem is a leading biotechnology and diagnostic company developing near patient PCR
assays on our Genedrive platform. Genedrive is a major advance in molecular diagnostic
testing by providing a rapid, low cost, simple to use 'Point of Care' device with high sensitivity
and specificity for use in the diagnosis of infectious diseases and companion diagnostic tests.
Epistem has developed an IL28B genotyping test which is conducted from buccal swabs
with results obtained in 45 minutes of sample collection. Viral detection, viral load and
HepC genotyping tests are in development.
Vienna, Austria • April 22–26, 2015 393
5, Leinenweberstrasse
Freiburg, 79108
Germany
www.drfalkpharma.de
Dr. Falk Pharma GmbH is an independent family owned enterprise based in Freiburg/
Germany with affiliates in UK,The Benelux countries, Spain, Portugal and Russia. Dr. Falk
Pharma and its approximately 200 employees are specialised in the development and sales
of medication for indications in hepatology and gastroenterology.These, mainly prescription
drugs, are sold in more than 60 countries worldwide.
The Falk Foundation e.V. is an independent organisation associated with Dr. Falk Pharma,
offering a wide variety of congresses and media to support postgraduate education for
doctors on a national and international level.
Echosens 320 A
30 place d'Italie
Paris, 75013
France
www.echosens.com
Echosens is a pioneer in non-invasive diagnosis solutions in hepatology. FibroScan®, based on
proprietaryVCTE: the only worldwide clinically validated medical device using elastography
(+900 publications). FibroMeter: a range of scores combining blood biomarkers to measure
fibrosis in the liver. FibroView: a range of smart connectivity solutions.
Epistem Ltd 250 D
48 Grafton Street
INDUSTRY INFORMATION
Manchester, M13 9XX
United Kingdom
www.epistem.co.uk or www.genedrive.com
Epistem is a leading biotechnology and diagnostic company developing near patient PCR
assays on our Genedrive platform. Genedrive is a major advance in molecular diagnostic
testing by providing a rapid, low cost, simple to use 'Point of Care' device with high sensitivity
and specificity for use in the diagnosis of infectious diseases and companion diagnostic tests.
Epistem has developed an IL28B genotyping test which is conducted from buccal swabs
with results obtained in 45 minutes of sample collection. Viral detection, viral load and
HepC genotyping tests are in development.
Vienna, Austria • April 22–26, 2015 393
